Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART 44 vs ART 50 in Knee Osteoarthritis
NCT01009671Phase 3Unknown
- Sponsor
- Negma Group
- Start
- Nov 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ART-44 in knee osteoarthritis (OA), sponsored by Negma Group. Status: unknown.
02
Drugs
ART-44
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01009671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009671.